Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC
Clinical trial NCT04043195 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04043195
- Sponsor
- Hatim Husain
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-14
- Primary completion
- 2025-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.